One of Colombia’s most prominent arbitrators, Eduardo Zuleta, is leaving his firm of eight years to launch a "chambers" in Bogota dedicated to international arbitration and human rights.
24 January 2017
Swiss pharmaceuticals group Novartis has threatened Colombia with an investment treaty claim over plans to impose price controls on a patented treatment for leukaemia, it has emerged.
02 December 2016
03 November 2016
03 November 2016
Unlock unlimited access to all Global Arbitration Review content